{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:46:39Z","timestamp":1784933199816,"version":"3.55.0"},"reference-count":47,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2021.10647","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T16:25:45Z","timestamp":1629822345000},"source":"Crossref","is-referenced-by-count":11,"title":["Anti\u2011inflammation treatment for protection of hepatocytes and amelioration of hepatic fibrosis in rats"],"prefix":"10.3892","volume":"22","author":[{"given":"Shi","family":"Feng","sequence":"first","affiliation":[{"name":"Key Laboratory of Brain Science Research and Transformation in Tropical Environment of Hainan Province, Hainan Medical University, Haikou, Hainan 571199, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Tong","sequence":"additional","affiliation":[{"name":"Division of Peptides Related with Human Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hang","family":"Gao","sequence":"additional","affiliation":[{"name":"Division of Peptides Related with Human Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Hang","family":"Tang","sequence":"additional","affiliation":[{"name":"Division of Peptides Related with Human Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Juan","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Peptides Related with Human Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Ming","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, West China School of Basic Medical Science and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, West China School of Basic Medical Science and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Lei","family":"Wen","sequence":"additional","affiliation":[{"name":"Key Laboratory of Brain Science Research and Transformation in Tropical Environment of Hainan Province, Hainan Medical University, Haikou, Hainan 571199, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2021,8,24]]},"reference":[{"key":"key20211014132347_b1-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol Aspects Med"},{"key":"key20211014132347_b2-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/lt.25320","article-title":"Liver transplantation today: Where we are now and where we are going","volume":"24","author":"Bodzin","year":"2018","journal-title":"Liver Transpl"},{"key":"key20211014132347_b3-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s11033-021-06171-w","article-title":"Research progress of natural compounds in anti-liver fibrosis by affecting autophagy of hepatic stellate cells","volume":"48","author":"Shu","year":"2021","journal-title":"Mol Biol Rep"},{"key":"key20211014132347_b4-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0036-1597816","article-title":"Regression of liver fibrosis","volume":"37","author":"Campana","year":"2017","journal-title":"Semin Liver Dis"},{"key":"key20211014132347_b5-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/sjg.SJG_297_17","article-title":"Involvement of epithelial-mesenchymal transition in liver fibrosis","volume":"24","author":"Yu","year":"2018","journal-title":"Saudi J Gastroenterol"},{"key":"key20211014132347_b6-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"G881","DOI":"10.1152\/ajpgi.00289.2013","article-title":"Evidence for and against epithelial-to-mesenchymal transition in the liver","volume":"305","author":"Xie","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"key20211014132347_b7-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/hep.23368","article-title":"Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice","volume":"51","author":"Taura","year":"2010","journal-title":"Hepatology"},{"key":"key20211014132347_b8-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1111\/jgh.12641","article-title":"Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial-to-mesenchymal transition of hepatocytes","volume":"29","author":"Wen","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"issue":"869390","key":"key20211014132347_b9-etm-0-0-10647","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/869390","article-title":"Autophagy: A multifaceted partner in liver fibrosis","volume":"2014","author":"Mallat","year":"2014","journal-title":"Biomed Res Int"},{"key":"key20211014132347_b10-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: A translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"key20211014132347_b11-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1194\/jlr.R800042-JLR200","article-title":"Cyclooxygenases: Structural and functional insights","volume":"50 (Suppl)","author":"Rouzer","year":"2009","journal-title":"J Lipid Res"},{"key":"key20211014132347_b12-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/gut.2006.115972","article-title":"Complex roles of cyclo-oxygenase 2 in hepatitis","volume":"56","author":"Holt","year":"2007","journal-title":"Gut"},{"key":"key20211014132347_b13-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jhep.2015.06.015","article-title":"Structural and functional hepatocyte polarity and liver disease","volume":"63","author":"Gissen","year":"2015","journal-title":"J Hepatol"},{"key":"key20211014132347_b14-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1530\/eje.1.02354","article-title":"Novel insights in somatostatin receptor physiology","volume":"156","author":"Tulipano","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"key20211014132347_b15-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1385\/ENDO:20:3:255","article-title":"Somatostatin and somatostatin receptor physiology","volume":"20","author":"Barnett","year":"2003","journal-title":"Endocrine"},{"key":"key20211014132347_b16-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2174\/1389450116666141205163548","article-title":"Somatostatin and its Analogs","volume":"17","author":"Sun","year":"2016","journal-title":"Curr Drug Targets"},{"key":"key20211014132347_b17-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/s0168-8278(02)00011-9","article-title":"Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality","volume":"36","author":"Li","year":"2002","journal-title":"J Hepatol"},{"key":"key20211014132347_b18-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"issue":"R19","key":"key20211014132347_b19-etm-0-0-10647","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-2-r19","article-title":"qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data","volume":"8","author":"Hellemans","year":"2007","journal-title":"Genome Biol"},{"issue":"691073","key":"key20211014132347_b20-etm-0-0-10647","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.691073","article-title":"Retinoic acid: A new old friend of IL-17A in the immune pathogeny of liver fibrosis","volume":"12","author":"Kartasheva-Ebertz","year":"2021","journal-title":"Front Immunol"},{"key":"key20211014132347_b21-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1055\/s-0037-1601350","article-title":"Inflammasomes in liver fibrosis","volume":"37","author":"Alegre","year":"2017","journal-title":"Semin Liver Dis"},{"key":"key20211014132347_b22-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"G962","DOI":"10.1152\/ajpgi.00428.2015","article-title":"Inhibition of cyclooxygenase-2 alleviates liver cirrhosis via improvement of the dysfunctional gut-liver axis in rats","volume":"310","author":"Gao","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"key20211014132347_b23-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1478-3231.2008.01760.x","article-title":"The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats","volume":"29","author":"Yu","year":"2009","journal-title":"Liver Int"},{"key":"key20211014132347_b24-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4318\/tjg.2010.0102","article-title":"Effects of a long-acting somatostatin analogue, lanreotide, on bile duct ligation-induced liver fibrosis in rats","volume":"21","author":"Tahan","year":"2010","journal-title":"Turk J Gastroenterol"},{"key":"key20211014132347_b25-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1478-3231.2005.01202.x","article-title":"Effect of celecoxib on experimental liver fibrosis in rat","volume":"26","author":"Hui","year":"2006","journal-title":"Liver Int"},{"key":"key20211014132347_b26-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1124\/mol.118.111831","article-title":"Celecoxib does not protect against fibrosis and inflammation in a carbon tetrachloride-induced model of liver injury","volume":"94","author":"Harris","year":"2018","journal-title":"Mol Pharmacol"},{"key":"key20211014132347_b27-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jhep.2011.02.001","article-title":"Epithelial-mesenchymal transition in chronic liver disease: Fibrogenesis or escape from death?","volume":"55","author":"Pinzani","year":"2011","journal-title":"J Hepatol"},{"key":"key20211014132347_b28-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4254\/wjh.v6.i4.207","article-title":"Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition","volume":"6","author":"Lee","year":"2014","journal-title":"World J Hepatol"},{"issue":"3672","key":"key20211014132347_b29-etm-0-0-10647","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113672","article-title":"Epithelial-mesenchymal transition and metastasis under the control of transforming growth factor \u03b2","volume":"19","author":"Tsubakihara","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"757","key":"key20211014132347_b30-etm-0-0-10647","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060757","article-title":"Snail1: A transcriptional factor controlled at multiple levels","volume":"8","author":"Baulida","year":"2019","journal-title":"J Clin Med"},{"key":"key20211014132347_b31-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1053\/j.gastro.2010.05.005","article-title":"Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice","volume":"139","author":"Scholten","year":"2010","journal-title":"Gastroenterology"},{"issue":"9","key":"key20211014132347_b32-etm-0-0-10647","doi-asserted-by":"publisher","DOI":"10.3390\/jcm5010009","article-title":"Controversies over the epithelial-to-mesenchymal transition in liver fibrosis","volume":"5","author":"Taura","year":"2016","journal-title":"J Clin Med"},{"issue":"1339","key":"key20211014132347_b33-etm-0-0-10647","doi-asserted-by":"publisher","DOI":"10.3390\/cells8111339","article-title":"Mechanisms underlying cell therapy in liver fibrosis: An overview","volume":"8","author":"Pinheiro","year":"2019","journal-title":"Cells"},{"key":"key20211014132347_b34-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20211014132347_b35-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1111\/febs.13665","article-title":"TGF-\u03b2 signalling and liver disease","volume":"283","author":"Fabregat","year":"2016","journal-title":"FEBS J"},{"key":"key20211014132347_b36-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/hep.24254","article-title":"Sorafenib inhibits transforming growth factor 1-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes","volume":"53","author":"Chen","year":"2011","journal-title":"Hepatology"},{"issue":"436242","key":"key20211014132347_b37-etm-0-0-10647","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/436242","article-title":"Autophagy in hepatic fibrosis","volume":"2014","author":"Song","year":"2014","journal-title":"BioMed research international"},{"key":"key20211014132347_b38-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/ncb2788","article-title":"Emerging regulation and functions of autophagy","volume":"15","author":"Boya","year":"2013","journal-title":"Nat Cell Biol"},{"key":"key20211014132347_b39-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jhep.2019.01.026","article-title":"Autophagy in liver diseases: Time for translation?","volume":"70","author":"Allaire","year":"2019","journal-title":"J Hepatol"},{"issue":"300","key":"key20211014132347_b40-etm-0-0-10647","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020300","article-title":"Diverse functions of autophagy in liver physiology and liver diseases","volume":"20","author":"Ke","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20211014132347_b41-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1080\/15384101.2021.1897241","article-title":"5-methoxytryptophan alleviates liver fibrosis by modulating FOXO3a\/miR-21\/ATG5 signaling pathway mediated autophagy","volume":"20","author":"Tong","year":"2021","journal-title":"Cell Cycle"},{"key":"key20211014132347_b42-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/path.5643","article-title":"Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2","volume":"254","author":"Kuscuoglu","year":"2021","journal-title":"J Pathol"},{"issue":"474","key":"key20211014132347_b43-etm-0-0-10647","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03749-x","article-title":"Fas\/FasL mediates NF-\u03baBp65\/PUMA-modulated hepatocytes apoptosis via autophagy to drive liver fibrosis","volume":"12","author":"Tan","year":"2021","journal-title":"Cell Death Dis"},{"issue":"28","key":"key20211014132347_b44-etm-0-0-10647","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.9460","article-title":"Shikonin reduces hepatic fibrosis by inducing apoptosis and inhibiting autophagy via the platelet-activating factor-mitogen-activated protein kinase axis","volume":"21","author":"Song","year":"2021","journal-title":"Exp Ther Med"},{"key":"key20211014132347_b45-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","article-title":"Mechanism and medical implications of mammalian autophagy","volume":"19","author":"Dikic","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20211014132347_b46-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00535-016-1216-y","article-title":"Evidence-based clinical practice guidelines for liver cirrhosis 2015","volume":"51","author":"Fukui","year":"2016","journal-title":"J Gastroenterol"},{"key":"key20211014132347_b47-etm-0-0-10647","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/hepr.13678","article-title":"Evidence-based clinical practice guidelines for Liver Cirrhosis 2020","volume":"56","author":"Yoshiji","year":"2021","journal-title":"J Gastroenterol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T12:29:36Z","timestamp":1634214576000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2021.10647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,8,24]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2021.10647","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,24]]},"article-number":"1213"}}